Setmelanotide
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Rhythm · Phase 3 · Recruiting · Enrollment 39
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Setemelanotide | Obesity or overweight | n/r | 26 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 26 | n/r | n/r |